ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.150
+0.070 (3.37%)
Nov 24, 2025, 4:00 PM EST - Market closed
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $2.12 billion as of November 24, 2025. Its market cap has decreased by -42.64% in one year.
Market Cap
2.12B
Enterprise Value
2.72B
1-Year Change
-42.64%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $2.12B, a decrease of -85.71%. That is a compound annual growth rate of -33.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 2.12B | 13.29% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | 14.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |